Nab-Paclitaxel Induced Cystoid Macular Oedema: Case Report and Literature Review. [PDF]
Shivarthi T, Haridas S, Pavithran K.
europepmc +1 more source
Impact of Antiglaucoma Drug Number and Class on Corneal Epithelial Thickness Measured by OCT. [PDF]
Miklaszewski P +8 more
europepmc +1 more source
Advanced bilateral glaucoma decades after first-generation Fyodorov 'collar-button' anterior-posterior phakic intraocular lens implantation: a case report and clinical management considerations. [PDF]
Sarnat-Kucharczyk M +5 more
europepmc +1 more source
A case of bilateral stellate nonhereditary idiopathic foveomacular retinoschisis with 14-month follow-up: clinical features, OCT findings and treatment outcome. [PDF]
Hassanpoor N +3 more
europepmc +1 more source
Drug induced hyperpigmentation: systematic review and meta-analysis. [PDF]
Alharithy R +7 more
europepmc +1 more source
Exudative Retinal Detachment Without Choroidal Effusion After Glaucoma Surgery in Sturge-Weber Syndrome. [PDF]
Perez AM +3 more
europepmc +1 more source
Late-Onset Scleral Flap Injury After Trabeculectomy Successfully Repaired Using a Preserved Scleral Patch: A Report of Two Cases. [PDF]
Okuno S +4 more
europepmc +1 more source
Related searches:
Clinical Pharmacokinetics of Dorzolamide
Clinical Pharmacokinetics, 2002Dorzolamide is a carbonic anhydrase inhibitor for topical ophthalmic application. It is used in the treatment of glaucoma to lower the intraocular pressure. After absorption via the cornea and stroma, it inhibits carbonic anhydrase in the ciliary process, which leads to a reduction of aqueous humour production and therefore to the desired therapeutic ...
Jens, Martens-Lobenhoffer +1 more
openaire +2 more sources

